Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Risk of reduced intestinal absorption of myo-inositol caused by D-chiro-inositol or by glucose transporter inhibitors
Authors
Keywords
-
Journal
Expert Opinion on Drug Metabolism & Toxicology
Volume 15, Issue 9, Pages 697-703
Publisher
Informa UK Limited
Online
2019-08-06
DOI
10.1080/17425255.2019.1651839
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparison of the effect of two combinations of myo-inositol and D-chiro-inositol in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
- (2019) Nicolas Mendoza et al. GYNECOLOGICAL ENDOCRINOLOGY
- The use of inositol(s) isomers in the management of polycystic ovary syndrome: a comprehensive review
- (2018) Antoaneta Gateva et al. GYNECOLOGICAL ENDOCRINOLOGY
- Inositol in Polycystic Ovary Syndrome: Restoring Fertility through a Pathophysiology-Based Approach
- (2018) Antonio Simone Laganà et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model
- (2018) Arturo Bevilacqua et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease
- (2016) Mariano Bizzarri et al. Expert Opinion on Drug Metabolism & Toxicology
- Inositol and human reproduction. From cellular metabolism to clinical use
- (2016) Ewa M. Milewska et al. GYNECOLOGICAL ENDOCRINOLOGY
- Combining treatment with myo-inositol andD-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients
- (2016) Giovanni Monastra et al. GYNECOLOGICAL ENDOCRINOLOGY
- Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state-of-the-art and future perspectives
- (2016) Cristiana Paul et al. GYNECOLOGICAL ENDOCRINOLOGY
- A Combined Therapy with Myo-Inositol and D-Chiro-Inositol Improves Endocrine Parameters and Insulin Resistance in PCOS Young Overweight Women
- (2016) Elena Benelli et al. International Journal of Endocrinology
- Polycystic ovary syndrome
- (2016) Ricardo Azziz et al. Nature Reviews Disease Primers
- The “Other” Inositols and Their Phosphates: Synthesis, Biology, and Medicine (with Recent Advances in myo -Inositol Chemistry)
- (2015) Mark P. Thomas et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Nutrition, Health, and Regulatory Aspects of Digestible Maltodextrins
- (2015) Denise L. Hofman et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Inositol transport proteins
- (2015) Sabine Schneider FEBS LETTERS
- Reflections on inositol(s) for PCOS therapy: steps toward success
- (2015) John E. Nestler et al. GYNECOLOGICAL ENDOCRINOLOGY
- Neuroprotective Effects of Lithium: Implications for the Treatment of Alzheimer’s Disease and Related Neurodegenerative Disorders
- (2014) O. V. Forlenza et al. ACS Chemical Neuroscience
- Hyperinsulinemia Alters Myoinositol to d-chiroinositol Ratio in the Follicular Fluid of Patients With PCOS
- (2014) Vittorio Unfer et al. Reproductive Sciences
- Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls
- (2013) Douglas Heimark et al. ENDOCRINE JOURNAL
- Myoinositol: Does It Improve Sperm Mitochondrial Function and Sperm Motility?
- (2012) Rosita A. Condorelli et al. UROLOGY
- Quantitative analysis of myo-inositol in urine, blood and nutritional supplements by high-performance liquid chromatography tandem mass spectrometry
- (2011) Kit-Yi Leung et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Inhibition of lung carcinogenesis and critical cancer-related signaling pathways by N-acetyl-S-(N-2-phenethylthiocarbamoyl)-l-cysteine, indole-3-carbinol and myo-inositol, alone and in combination
- (2010) F. Kassie et al. CARCINOGENESIS
- Sodium/myo-inositol cotransporter 1 and myo-inositol are essential for osteogenesis and bone formation
- (2010) Zhijie Dai et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome
- (2010) Domenico Giordano et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells
- (2008) Xiaobo Lin et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Inositol trisphosphate and calcium signalling mechanisms
- (2008) Michael J. Berridge BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Inositol derivatives: evolution and functions
- (2008) Robert H. Michell NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More